Login / Signup

Pregnancy outcomes in women with type 1 diabetes using insulin degludec.

Lene RingholmNicoline Callesen DoPeter DammElisabeth Reinhardt Mathiesen
Published in: Acta diabetologica (2022)
The use of degludec during pregnancy resulted in similar pregnancy outcomes as use of other long-acting insulin analogs in women with type 1 diabetes in a real-world setting. This suggests that degludec initiated before pregnancy can be continued throughout gestation.
Keyphrases
  • pregnancy outcomes
  • pregnant women
  • type diabetes
  • glycemic control
  • preterm infants
  • molecular docking
  • metabolic syndrome
  • gestational age
  • adipose tissue
  • cervical cancer screening